Teleflex has obtained market clearance from the US Food and Drug Administration (FDA) for its Arrow Seldinger arterial catheterisation device.

Indicated for short-term use, the Seldinger device is developed to eliminate the confusion of catheter identification, minimise complications risk associated with insertion, and offer an optimal diagnostic method for enhanced patient safety and effective treatment.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Expected to be commercially launched in the country’s market this year, the catheterisation device is available in various sizes to allow customisation based on patient, insertion site and application.

Teleflex Vascular Access division vice-president and general manager Jake Newman said: “As we continue to discover new and innovative solutions, the Seldinger arterial catheterisation device is now part of our extensive arterial offering in the US market.

“This innovative device is intended to facilitate ease of insertion and resistance to body collapse.”

“This innovative device is intended to facilitate ease of insertion and resistance to body collapse.”

The firm develops medical technology solutions for vascular and interventional access, surgical, anaesthesia, cardiac care, urology, emergency medicine, and respiratory care sectors.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Teleflex’s Arrow brand includes technically advanced vascular access devices with antimicrobial and antithrombogenic protection to avoid vascular-related complications.

The range offers long and short dwell central venous catheters (CVC), sheath introducers, arterial lines, peripherally inserted central catheters (PICC), devices for intraosseous vascular access, and vascular positioning system for placement of a PICC or CVC near the heart.

In addition to arterial products with the Seldinger technique, the brand comprises products with Smooth Needle Placement, Extension set, Suture Wings and Improved Guidewire.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact